Dr. Maller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 E Leigh St FL 4
Richmond, VA 23298Phone+1 804-828-7999Fax+1 804-828-5941
Summary
- Dr. Bradley Maller is an internal medicine specialist based in Richmond, VA, with subspecialties in Hematology and Oncology. He completed his medical degree at the University of South Florida College of Medicine in 2020, a residency in internal medicine at Virginia Commonwealth University Health System from 2020 to 2023, and is currently undertaking a fellowship in Hematology and Medical Oncology at the same institution, set to finish in 2026. His research contributions include several publications related to lung cancer, such as studies on intraocular metastasis, lung cancer screening approaches, and the impact of treatments on immunotherapy response, with his work being cited multiple times in academic literature.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2023 - 2026- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2020 - 2023
University of South Florida College of MedicineClass of 2020
Certifications & Licensure
VA State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 6 citationsOutcomes of Intraocular Metastasis From Lung Cancer in the Era of Targeted Therapy: A Systematic Review and Pooled Analysis.Bradley Maller, Sarah Salvatori, Tawee Tanvetyanon
Clinical Lung Cancer. 2022-12-01 - 2 citationsEmerging Approaches to Complement Low-Dose Computerized Tomography for Lung Cancer Screening: A Narrative Review.Bradley Maller, Tawee Tanvetyanon
Cureus. 2022-07-01 - 12 citationsEffect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer.Andrew F Nyein, Shahla Bari, Stephanie Hogue, Yayi Zhao, Bradley Maller
BMC Cancer. 2022-01-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
